ArticleEcancermedicalscience2026
Nutritional status at diagnosis and follow-up and its impact on short-term clinical outcome in children with cancer: a real-world report from India.
Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of nutritional screening tools in pediatric patients undergoing hematopoietic stem cell transplantation.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutritional status (NS) in children with cancer may impact a wide range of outcomes, and remediation of under and over-nutrition may potentially improve outcomes. Children with cancer at our centre were classified as undernourished (UN) body mass index (BMI Z-score ≤-2 standard deviations (SD) World Health Organisation (WHO) or mid-upper-arm circumference (MUAC) <12.5 cm for <5 years (WHO) or <25th percentile for >5 years (Frisancho)), well-nourished (WN) (BMI Z-score -1 SD to +1 SD or MUAC 12.5-13.5 cm for <5 years or 25-50th percentile for >5 years) and over-nourished (ON) (BMI Z-score ≥+1 SD or MUAC ≥75th percentile for >5 years). NS was assessed at three time-points: diagnosis, 3- and 6-month follow-up. Trends in NS and impact on outcomes (event-free survival (EFS) and overall survival) were analysed. At diagnosis (n = 2,086) and 6-month follow-up (n = 1,245), 30.9% and 41.7% were WN, 65.3% and 52.2% UN and 3.8% and 6.1% ON. During the course of treatment, 45.5% gained weight and 11.6% lost weight. The highest prevalence of undernutrition at diagnosis was seen in acute myeloid leukaemia (73.3%), lymphoma (68.8%) and bone tumours (68.7%). Two-year EFS was 71.3% ± 1.82% in WN children, 71.3% ± 5.19% in ON children and 68.4% ± 1.28% in children UN at diagnosis (p = 0.004). Children who gained weight between diagnosis and follow-up had a 2-year EFS of 82.8% ± 1.60% versus 76% ± 1.70% in those without weight gain (p = 0.022). Undernutrition at diagnosis as well as during treatment leads to increased relapse as well as mortality. Weight gain and improved NS appear to impact clinical outcomes, highlighting the need for targeted nutritional interventions in children with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.